Recent BioUtah News & Events

ReddyPort, a medical technology company focused on bringing new non-invasive ventilation (NIV) products into market

ELITechGroup is pleased to announce the CE mark for use of saliva on SARS-CoV-2 ELITe MGB® Kit.

The second calendar quarter (2Q) of 2021 financial results were dramatically different from 2Q 2020 because 2Q 2020 results were the low point of Utah Medical Products, Inc.’s (Nasdaq: UTMD) performance during the COVID-19 pandemic, during a time when there were restrictions on so-called nonessential medical procedures. Therefore, UTMD management reports quarterly income statement results compared to the same periods not only in 2021 compared to 2020, but also compared to 2019. The Company’s stated objective in 2021 has been to try to fully recover back to its 2019 financial performance. Please see the income statements for all three years on the last page. 

CenExel Clinical Research, Inc., (“CenExel”) announces the acquisition of ForCare Clinical Research (“CenExel FCR”), a Tampa-based clinical research organization with Principal Investigators who have more than 40 years of combined research experience. CenExel FCR conducts Phase I through Phase IV studies in both chronic and acute conditions, primarily in Dermatology

Biomerics LLC, a leading mid-market contract manufacturer for the interventional medical device market, announced it has acquired a majority interest in Berg Manufacturing Inc. Berg Manufacturing, based in Santa Clara, California, is an industry leader in Swiss micromachining for the advanced robotic surgery, endoscope, and interventional catheter markets.

Advancing its mission to expand access to genetic testing, Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today launched a new version of its market-leading MyRisk Hereditary Cancer Test. For the first time, women of all ancestries can now receive a personalized polygenic breast cancer risk assessment together with the market’s most accurate hereditary cancer test.

Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced financial results for its second quarter ended June 30, 2021 and provided an update on recent business performance and strategic transformation plans.

PolarityTE on July 28 announced final data from a multi-center randomized controlled trial evaluating treatment of Diabetic Foot Ulcers (DFU) with its investigational product SkinTE®. The trial met the primary endpoint of wound closure at 12 weeks and secondary endpoint of Percent Area Reduction (PAR) assessed at 4, 6, 8, 10, and 12 weeks. Nikolai […]

PolarityTE recently announced that the China National Intellectual Property Administration (CNIPA) issued a Notification of Allowance for Chinese Patent Application No. 201580075326.3. The allowed claims relate to skin-regenerative compositions utilizing PolarityTE’s minimally polarized functional unit (MPFU) technology as well as methods of making a skin-regenerative composition utilizing the MPFU technology. This most recent allowance further […]

PolarityTE on Monday announced the submission of an investigational new drug application (IND) to the FDA seeking authorization to commence a clinical trial to evaluate its SkinTE product for the proposed indication of treatment of chronic cutaneous ulcers. SkinTE is PolarityTE’s human cellular and tissue-based product derived from a patient’s own skin. David Seaburg, Chief Executive […]

Last week, Foldax presented on the company’s innovative Tria valve at the 2021 Transcatheter Valve Technologies (TVT) meeting. View the slides HERE. The presentation titled “Foldax Biopolymer Valves: An Alternative to Tissue Based Leaflet Valves” was given by Foldax investigator, Dr. David Heimansohn, chief of surgery at St. Vincent/Ascension in Indiana and was well received. […]

U.S. Senator Mike Lee (R-UT) on July 16 toured Stryker’s Neurovascular Division with division President, Mark Paul, joined by BioUtah President and CEO, Kelvyn Cullimore and members of the Senator’s staff. During the tour, Lee learned about the innovative, best-in-class technologies manufactured at the Salt Lake City facility to treat stroke patients. Stroke is the […]

Co-Diagnostics has added to its suite of intellectual property protection after being awarded a patent from the Republic of Korea’s Intellectual Property Office for the Company’s CoPrimer™ technology. Developed in 2013, Co-Diagnostics’ solely-owned CoPrimer technology received its first patent from the US Patent Office in 2018, and underpins the company’s molecular diagnostic test products that […]

South Salt Lake-based R-Zero, the first biosafety technology company dedicated to creating safer, healthier indoor spaces, announced July 20 its acquisition of CoWorkr, the leading property technology company offering privacy-first space utilization sensors for data-driven workplaces. Fresh off its Series B raise closed in June, R-Zero’s first acquisition accelerates speed to market for an IoT […]

Owlet on July 15 announced that it completed its business combination with Sandbridge Acquisition Corporation, a special purpose acquisition company (SPAC) as previously announced in February. Following the transaction, the company was renamed Owlet, Inc, and its Class A common stock and warrants began trading on the New York Stock Exchange under the symbols “OWLT” […]

Sera Prognostics – The Pregnancy Company® – located in Salt Lake City, Utah, has announced the pricing of its initial public offering of 4,687,500 shares of its common stock at a price to the public of $16.00 per share. Sera is a women’s health diagnostics company dedicated to improving the lives of women and babies […]

MMV, a Salt Lake City-based seed-stage venture capital firm, announced the first close of its second fund, MMVII. The fund will be managed by Managing Partners Branden Rosenhan, MD, Saumitra Thakur, MD and General Partner and COO Katelin Roberts. “95% of our first fund investors have joined us in MMVII, many stepping up their commitments. […]

Nusano, a health-tech company aiming to revolutionize uranium-free radioisotope development and production in various diagnostic and therapeutic medical applications, is opening an office in Utah. The Governor’s Office of Economic Opportunity (Go Utah) announced the news July 8, noting that the company will add up to 92 new high-paying Utah jobs in the next 15 […]

Turner Imaging Systems has entered a distribution agreement with MIS Healthcare to market its Smart-C fluoroscopic Mini C-Arm in the UK and Ireland. MIS Healthcare, with headquarters in London, is a large, independent medical imaging equipment supplier throughout the UK and Ireland, servicing NHS and HSE hospitals as well as private hospitals, clinics, screening centers […]

Major League Baseball has expanded its partnership with Spectrum Solutions to facilitate a COVID-19 testing program throughout the 2021 Minor League season. Under the partnership, Spectrum will be supplying all Major League and Minor League teams with its innovative SDNA-1000 saliva collection kits for all player and staff testing. Spectrum Solutions has also consulted with […]

In May, Spectrum Solutions was awarded the prestigious Best of State® award in the Science & Technology category for Medical Innovation. Spectrum received this honor for its SDNA-1000 Saliva Collection Device. “At Spectrum Solutions, our focus is on creating forward-looking and scalable end-to-end solutions for applications such as clinical diagnostics and commercialized product plans.” said […]

Park City based and BioUtah member, BlueWind Medical, has announced its 100th patient implant in their pivotal study – Overactive Bladder (OAB) Stimulation System Study (OASIS) – for treating overactive bladder symptoms using the company’s innovative medical device the RENOVA™ iStim. The milestone marks an important step towards FDA clearance for the device. “The 100th […]

Thermo Fisher is opening a new facility at the Boyer Business Depot Ogden, hiring 450 employees by 2022. Ogden City announced the plans on Tuesday. “Thermo Fisher has had a presence in Utah for many years,” said Kelvyn Cullimore, president and CEO of BioUtah. “The company’s expansion in Ogden reflects their commitment to Utah jobs, […]

Recursion has announced a multi-year collaboration with Mila, the Quebec Artificial Intelligence Institute, to accelerate Recursion’s machine learning capabilities. Recursion will open office space within Mila and build a team focused on using machine learning for tech-enabled drug discovery. “Recursion is executing at the forefront of multiple technical fields including biology, chemistry, automation, engineering and […]

BioUtah congratulates the Epitel team on its first peer-reviewed manuscript, “Electrographic Seizure Monitoring with a Novel, Wireless, Single-Channel EEG Sensor,” comparing Epilog EEG to the clinical gold-standard of traditional EEG. The publication appears in Clinical Neurophysiology Practice. People living with epilepsy could benefit by having a more accurate and objective wearable EEG system for counting seizures […]

Renalytix has announced new data demonstrating KidneyIntelX™ can be effective at monitoring therapeutic response and improvements in kidney health in adults with type 2 diabetes. The data from an international study of 1,100 individuals with diabetic kidney disease (DKD) in the CANagliflozin Cardiovascular Assessment Study (CANVAS), was presented at the American Diabetes Association 81st Scientific Sessions […]

BioUtah has contracted with G2G, Washington DC’s premier consulting firm for non-dilutive funding, to receive a detailed monthly report on the funding landscape.

Phoenix PharmaLabs, Inc. has completed a second successful round of financing raising $1.07 million via the Netcapital equity funding portal to continue development of two non-addictive opioids to treat acute and chronic pain. “More than a thousand investors, many of whom invested in our previous funding, participated in this offering, indicating to us they did […]

Co-Diagnostics has obtained regulatory authorization to be sold as an in vitro diagnostic (“IVD”) for the diagnosis of COVID-19 in markets that accept CE markings. The Co-Diagnostics Logix Smart DS test kit detects the presence of certain genes of the COVID-19 virus directly from human saliva samples while eliminating RNA extraction of the samples. Eliminating […]

Turner Imaging Systems has won a small Business Technology Transfer (STTR) Phase I contract from the U.S. Air Force. Turner will use the non-dilutive funds to develop a next generation compact, highly portable, battery-powered full-body fluoroscopic X-ray (Smart-C) to help Special Operations Surgical Teams, Army Forward Surgical Teams (FSTs), and Navy Fleet Surgical Teams, save […]

Organized by World Trade Center Utah and the Governor’s Office of Economic Development (GOED), eight Utah life sciences companies recently represented the state and our industry in Dubai, as part of the Arab Health trade show. The delegation exhibited in a booth showcasing the companies and BioHive. Quansys Biosciences, Turner Imaging Solutions and Zehn-X LLC, […]

Tula Health recently raised $24.1 million in debt and equity financing from two venture firms – Springtide Ventures, a health tech venture firm based in Utah and Boston, and Sandbox Capital Advisors based in Salt Lake City. The company creates behavioral change guidance via on-call support, and supporting hardware and software to help their customers […]